Targeted therapies: Afatinib--new therapy option for EGFR-mutant lung cancer. Article uri icon

Overview

publication date

  • August 20, 2013

Research

keywords

  • Carcinoma, Non-Small-Cell Lung
  • ErbB Receptors
  • Lung Neoplasms
  • Molecular Targeted Therapy
  • Mutation
  • Quinazolines

Identity

PubMed Central ID

  • PMC4665630

Scopus Document Identifier

  • 84885022898

Digital Object Identifier (DOI)

  • 10.1038/nrclinonc.2013.154

PubMed ID

  • 23959269

Additional Document Info

volume

  • 10

issue

  • 10